ARCHIVES

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 03 | January 17, 2003

Download PDF Visit The Full Archive

Related Articles

Fluoride Study Update Finds No Increased Risk

October 19, 1990

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

Preliminary Action Plan Seeks Consumer Representation

January 7, 1994

Susan Weiner Named to HHS Panel

January 17, 2003

Cancer Letter Skips Next Two Weeks

September 2, 1988

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974